These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38016860)

  • 1. Determinants of persistent symptoms after treatment for Lyme borreliosis: a prospective observational cohort study.
    Vrijmoeth HD; Ursinus J; Harms MG; Tulen AD; Baarsma ME; van de Schoor FR; Gauw SA; Zomer TP; Vermeeren YM; Ferreira JA; Sprong H; Kremer K; Knoop H; Joosten LAB; Kullberg BJ; Hovius JW; van den Wijngaard CC
    EBioMedicine; 2023 Dec; 98():104825. PubMed ID: 38016860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and determinants of persistent symptoms after treatment for Lyme borreliosis: study protocol for an observational, prospective cohort study (LymeProspect).
    Vrijmoeth HD; Ursinus J; Harms MG; Zomer TP; Gauw SA; Tulen AD; Kremer K; Sprong H; Knoop H; Vermeeren YM; van Kooten B; Joosten LAB; Kullberg BJ; Hovius JWR; van den Wijngaard CC
    BMC Infect Dis; 2019 Apr; 19(1):324. PubMed ID: 30987580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of persistent symptoms after treatment for lyme borreliosis: A prospective observational cohort study.
    Ursinus J; Vrijmoeth HD; Harms MG; Tulen AD; Knoop H; Gauw SA; Zomer TP; Wong A; Friesema IHM; Vermeeren YM; Joosten LAB; Hovius JW; Kullberg BJ; van den Wijngaard CC
    Lancet Reg Health Eur; 2021 Jul; 6():100142. PubMed ID: 34557833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation and 1-year follow-up of patients presenting at a Lyme borreliosis expertise centre: a prospective cohort study with validated questionnaires.
    van de Schoor FR; Baarsma ME; Gauw SA; Ursinus J; Vrijmoeth HD; Ter Hofstede HJM; Tulen AD; Harms MG; Wong A; van den Wijngaard CC; Joosten LAB; Hovius JW; Kullberg BJ
    Eur J Clin Microbiol Infect Dis; 2024 May; 43(5):937-946. PubMed ID: 38492058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-specific symptoms and post-treatment Lyme disease syndrome in patients with Lyme borreliosis: a prospective cohort study in Belgium (2016-2020).
    Geebelen L; Lernout T; Devleesschauwer B; Kabamba-Mukadi B; Saegeman V; Belkhir L; De Munter P; Dubois B; Westhovens R; ; Van Oyen H; Speybroeck N; Tersago K
    BMC Infect Dis; 2022 Sep; 22(1):756. PubMed ID: 36171561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of cellular tests for Lyme borreliosis (VICTORY) study.
    van de Schoor FR; Baarsma ME; Gauw SA; Joosten LAB; Kullberg BJ; van den Wijngaard CC; Hovius JW
    BMC Infect Dis; 2019 Aug; 19(1):732. PubMed ID: 31429716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptom load and general function among patients with erythema migrans: a prospective study with a 1-year follow-up after antibiotic treatment in Norwegian general practice.
    Eliassen KE; Hjetland R; Reiso H; Lindbæk M; Tschudi-Madsen H
    Scand J Prim Health Care; 2017 Mar; 35(1):75-83. PubMed ID: 28277054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Lyme borreliosis diagnosis probability score - no relation with antibiotic treatment response.
    Briciu VT; Flonta M; Leucuţa D; Cârstina D; Ţăţulescu DF; Lupşe M
    Infect Dis (Lond); 2017 May; 49(5):373-379. PubMed ID: 28049383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional signs in patients consulting for presumed Lyme borreliosis.
    Voitey M; Bouiller K; Chirouze C; Fournier D; Bozon F; Klopfenstein T
    Med Mal Infect; 2020 Aug; 50(5):423-427. PubMed ID: 31722861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent Lyme Empiric Antibiotic Study Europe (PLEASE)--design of a randomized controlled trial of prolonged antibiotic treatment in patients with persistent symptoms attributed to Lyme borreliosis.
    Berende A; ter Hofstede HJ; Donders AR; van Middendorp H; Kessels RP; Adang EM; Vos FJ; Evers AW; Kullberg BJ
    BMC Infect Dis; 2014 Oct; 14():543. PubMed ID: 25318999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonspecific Symptoms in Children Referred to a Lyme Borreliosis Center.
    Zomer TP; Bruinsma RA; Vermeeren YM; Landman GW; van Hees BC; van Bemmel T; van Kooten B
    Pediatr Infect Dis J; 2020 Sep; 39(9):775-780. PubMed ID: 32379202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of Lyme Borreliosis in the Dutch General Practice Population: A Large-Scale Population-Based Cohort Study Across the Netherlands Between 2015 and 2019.
    Houben E; de Jong H; Penning-van Beest F; Kuiper J; Holthuis E; Blum M; Skufca J; Riera-Montes M; Gessner BD; Pilz A; Vyse AJ; Begier E; Dzingina M; Herings R; Stark JH
    Vector Borne Zoonotic Dis; 2023 Apr; 23(4):230-236. PubMed ID: 37071403
    [No Abstract]   [Full Text] [Related]  

  • 13. Lyme borreliosis in Belgium: a cost-of-illness analysis.
    Geebelen L; Devleesschauwer B; Lernout T; Tersago K; Parmentier Y; Van Oyen H; Speybroeck N; Beutels P
    BMC Public Health; 2022 Nov; 22(1):2194. PubMed ID: 36443755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of Borrelia IgG antibodies among young Swedish children in relation to reported tick bites, symptoms and previous treatment for Lyme borreliosis: a population-based survey.
    Skogman BH; Ekerfelt C; Ludvigsson J; Forsberg P
    Arch Dis Child; 2010 Dec; 95(12):1013-6. PubMed ID: 20702388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depressive Symptoms in Patients Referred to a Tertiary Lyme Center: High Prevalence in Those Without Evidence of Lyme Borreliosis.
    Zomer TP; Vermeeren YM; Landman GW; Zwerink M; van Hees BC; van Bemmel T; van Kooten B
    Clin Infect Dis; 2017 Oct; 65(10):1689-1694. PubMed ID: 29020278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memory functioning in Lyme borreliosis.
    Ravdin LD; Hilton E; Primeau M; Clements C; Barr WB
    J Clin Psychiatry; 1996 Jul; 57(7):282-6. PubMed ID: 8666568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-specific symptoms in adult patients referred to a Lyme centre.
    Zomer TP; Barendregt JNM; van Kooten B; van Bemmel T; Landman GW; van Hees BC; Vermeeren YM
    Clin Microbiol Infect; 2019 Jan; 25(1):67-70. PubMed ID: 30287411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lyme borreliosis in pediatric population: Clinical, diagnostic and therapeutic features.
    Rubio Granda A; Fernández-Miaja M; Rodríguez Pérez M; Calle-Miguel L
    Enferm Infecc Microbiol Clin (Engl Ed); 2024 Feb; 42(2):93-97. PubMed ID: 37419748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of Lyme Disease in a Highly Endemic European Zone.
    Petrulionienė A; Radzišauskienė D; Ambrozaitis A; Čaplinskas S; Paulauskas A; Venalis A
    Medicina (Kaunas); 2020 Mar; 56(3):. PubMed ID: 32151097
    [No Abstract]   [Full Text] [Related]  

  • 20. The cost of Lyme borreliosis.
    van den Wijngaard CC; Hofhuis A; Wong A; Harms MG; de Wit GA; Lugnér AK; Suijkerbuijk AWM; Mangen MJ; van Pelt W
    Eur J Public Health; 2017 Jun; 27(3):538-547. PubMed ID: 28444236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.